The Mirasol Pathogen Reduction Technology (PRT) System renders a broad range of disease-causing viruses, bacteria and parasites less pathogenic, and inactivates residual white blood cells found in blood components.
Built for efficiency and ease of use, the novel Mirasol PRT system helps improve the safety of the blood supply by reducing the infectious levels of disease-causing agents in platelets and plasma while still maintaining quality blood components.
The Mirasol PRT system is:
- An innovative, proactive approach to addressing existing and emerging safety issues
- The only device that uses riboflavin (vitamin B2), a naturally occurring, non-toxic compound, combined with ultraviolet light, to provide effective pathogen reduction and white cell inactivation
- A single platform capable of treating platelets and plasma using the same compound and light delivery system
- Versatile technology that is easy to learn and use
The Mirasol PRT system delivers:
- An extra measure of safety in the face of emerging infectious diseases
- Reduced risk from screened and unscreened pathogens and white blood cells
- An effective alternative to bacterial screening of platelets, with no delay in product release
- Flexibility and ease of use for optimal operational efficiency
- Accurate reporting and traceability through fully integrated data capture
CONTACT SALES TODAY VIEW HOW IT WORKS
The Mirasol PRT System is in conformance with the Medical Device Directive and is available in select markets. However, the Mirasol PRT System is not for sale in the U.S.